A synthetic peptide for use as a blocking control in assays to test for specificity of FLII antibody, Alternative Names: FLII control peptide, FLII antibody Blocking Peptide, Anti-FLII Blocking Peptide, Flightless I Homolog Blocking Peptide, FLI Blocking Peptide, FLIL Blocking Peptide, Fli1 Blocking Peptide, MGC39265 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
FLII
(Flightless I Homolog (FLII))
Hintergrund
FLII is a protein with a gelsolin-like actin binding domain and an N-terminal leucine-rich repeat-protein protein interaction domain. The protein is similar to a Drosophila protein involved in early embryogenesis and the structural organization of indirect flight muscle. This gene is located within the Smith-Magenis syndrome region on chromosome 17.